Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,668 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX®) in female school students in Thailand.
Jiamsiri S, Rhee C, Ahn HS, Poudyal N, Seo HW, Klinsupa W, Nilyanimit P, Premsri N, Namwat C, Vonpunsawad S, Chon Y, Park S, Kim DR, Unger ER, Markowitz L, Poovorawan Y, Rerks-Ngarm S, Excler JL, Lynch J. Jiamsiri S, et al. Among authors: lynch j. PLoS One. 2022 Apr 28;17(4):e0267294. doi: 10.1371/journal.pone.0267294. eCollection 2022. PLoS One. 2022. PMID: 35482803 Free PMC article.
Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children.
Capeding MR, Teshome S, Saluja T, Syed KA, Kim DR, Park JY, Yang JS, Kim YH, Park J, Jo SK, Chon Y, Kothari S, Yang SY, Ham DS, Ryu JH, Hwang HS, Mun JH, Lynch JA, Kim JH, Kim H, Excler JL, Sahastrabuddhe S. Capeding MR, et al. Among authors: lynch ja. Vaccine. 2018 Jun 18;36(26):3794-3801. doi: 10.1016/j.vaccine.2018.05.038. Vaccine. 2018. PMID: 29776750 Free PMC article. Clinical Trial.
Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report.
Capeding MR, Alberto E, Sil A, Saluja T, Teshome S, Kim DR, Park JY, Yang JS, Chinaworapong S, Park J, Jo SK, Chon Y, Yang SY, Ham DS, Ryu JH, Lynch J, Kim JH, Kim H, Excler JL, Wartel TA, Sahastrabuddhe S. Capeding MR, et al. Among authors: lynch j. Vaccine. 2020 Jun 9;38(28):4476-4483. doi: 10.1016/j.vaccine.2019.09.074. Epub 2019 Oct 1. Vaccine. 2020. PMID: 31585725 Free PMC article. Clinical Trial.
Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study.
Capeding MR, Sil A, Tadesse BT, Saluja T, Teshome S, Alberto E, Kim DR, Park EL, Park JY, Yang JS, Chinaworapong S, Park J, Jo SK, Chon Y, Yang SY, Ryu JH, Cheong I, Shim KY, Lee Y, Kim H, Lynch JA, Kim JH, Excler JL, Wartel TA, Sahastrabuddhe S. Capeding MR, et al. Among authors: lynch ja. EClinicalMedicine. 2020 Sep 9;27:100540. doi: 10.1016/j.eclinm.2020.100540. eCollection 2020 Oct. EClinicalMedicine. 2020. PMID: 33150320 Free PMC article.
Prevalence of HPV infection among Thai schoolgirls in the north-eastern provinces in 2018: implications for HPV immunization policy.
Vongpunsawad S, Rhee C, Nilyanimit P, Poudyal N, Jiamsiri S, Ahn HS, Lee J, Seo HW, Klinsupa W, Park S, Premsri N, Namwat C, Silaporn P, Excler JL, Kim DR, Markowitz LE, Unger ER, Rerks-Ngarm S, Lynch J, Poovorawan Y. Vongpunsawad S, et al. Among authors: lynch j. IJID Reg. 2023 Mar 4;7:110-115. doi: 10.1016/j.ijregi.2023.02.011. eCollection 2023 Jun. IJID Reg. 2023. PMID: 37009571 Free PMC article.
Comparable detection of HPV using real-time PCR in paired cervical samples and concentrated first-stream urine collected with Colli-Pee device.
Nilyanimit P, Chaithongwongwatthana S, Oranratanaphan S, Poudyal N, Excler JL, Lynch J, Vongpunsawad S, Poovorawan Y. Nilyanimit P, et al. Among authors: lynch j. Diagn Microbiol Infect Dis. 2024 Mar;108(3):116160. doi: 10.1016/j.diagmicrobio.2023.116160. Epub 2023 Dec 12. Diagn Microbiol Infect Dis. 2024. PMID: 38184985 Free PMC article.
Oral Cholera Vaccine Efficacy and Effectiveness.
Song KR, Lim JK, Park SE, Saluja T, Cho SI, Wartel TA, Lynch J. Song KR, et al. Among authors: lynch j. Vaccines (Basel). 2021 Dec 15;9(12):1482. doi: 10.3390/vaccines9121482. Vaccines (Basel). 2021. PMID: 34960228 Free PMC article. Review.
A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh.
Chowdhury F, Akter A, Bhuiyan TR, Tauheed I, Teshome S, Sil A, Park JY, Chon Y, Ferdous J, Basher SR, Ahmed F, Karim M, Ahasan MM, Mia MR, Masud MMI, Khan AW, Billah M, Nahar Z, Khan I, Ross AG, Kim DR, Ashik MMR, Digilio L, Lynch J, Excler JL, Clemens JD, Qadri F. Chowdhury F, et al. Among authors: lynch j. Vaccine. 2022 Jan 28;40(4):640-649. doi: 10.1016/j.vaccine.2021.12.015. Epub 2021 Dec 27. Vaccine. 2022. PMID: 34969541 Free article. Clinical Trial.
Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis.
Bi Q, Ferreras E, Pezzoli L, Legros D, Ivers LC, Date K, Qadri F, Digilio L, Sack DA, Ali M, Lessler J, Luquero FJ, Azman AS; Oral Cholera Vaccine Working Group of The Global Task Force on Cholera Control. Bi Q, et al. Lancet Infect Dis. 2017 Oct;17(10):1080-1088. doi: 10.1016/S1473-3099(17)30359-6. Epub 2017 Jul 17. Lancet Infect Dis. 2017. PMID: 28729167 Free PMC article. Review.
4,668 results